anti-PIIINP antibody product blog
Tags: Antibody; Monoclonal Antibody; Procollagen III N-Terminal Propeptide (PIIINP); PIIINP; anti-PIIINP antibody;
The PIIINP n/a (Catalog #MBS2044379) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The HRP-Linked Monoclonal Antibody to Procollagen III N-Terminal Propeptide (PIIINP) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Procollagen III N-Terminal Propeptide (PIIINP) can be used in a range of immunoassay formats including, but not limited to, IHC; ICC.Western blotting: 0.5-2�g/mL
Immunohistochemistry: 5-20�g/mL
Immunocytochemistry: 5-20�g/mL
Optimal working dilutions must be determined by end user . Researchers should empirically determine the suitability of the PIIINP n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. The amino acid sequence is listed below:
RDVWKPEPCQ ICVCD.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the HRP-Linked Monoclonal Antibody to Procollagen III N-Terminal Propeptide (PIIINP) with the following immunoassay(s):
DAB staining on IHC-P (A. Human Liver Tissue
B. Human Kidney Tissue
C. Human Glioma Tissue
D. Human Stomach Tissue)
Source: Monoclonal antibody preparation
Label: HRP
Traits: Liquid
Immunogen: Synthetic Peptide, PIIINP conjugated to OVA
Cross Reactivity: Human, Rat. Unconjugated Antibody: The unconjugated antibody version of this item is also available as catalog #MBS2025794. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing PIIINP are readily searchable from our website. Different antibodies against the same target such as PIIINP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.